{
    "2020-10-20": [
        [
            {
                "time": "2018-03-15",
                "original_text": "AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "stock sinks",
                        "market gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Were Hedge Funds Right About Crowding AbbVie Inc (ABBV)?",
                "features": {
                    "keywords": [
                        "hedge funds",
                        "right",
                        "crowding",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "AbbVie (ABBV) Files for Rinvoq in Atopic Dermatitis in US & EU",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Rinvoq",
                        "atopic dermatitis",
                        "US",
                        "EU"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "AbbVie Submits US, EU Rinvoq Applications For Atopic Dermatitis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "submits",
                        "US",
                        "EU",
                        "Rinvoq",
                        "applications",
                        "atopic dermatitis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}